...
首页> 外文期刊>Oncology Research >Downregulation of SRC Kinase Signaling Inhibitor 1 (SRCIN1) Expression by MicroRNA-32 Promotes Proliferation and Epithelial-Mesenchymal Transition in Human Liver Cancer Cells
【24h】

Downregulation of SRC Kinase Signaling Inhibitor 1 (SRCIN1) Expression by MicroRNA-32 Promotes Proliferation and Epithelial-Mesenchymal Transition in Human Liver Cancer Cells

机译:SRC激酶信号抑制剂1(SRCIN1)表达的MicroRNA-32的下调促进人肝癌细胞中的增殖和上皮 - 间充质转变

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

MicroRNAs play an important role in regulating gene expression by binding to the 3'-UTR of target mRNAs. In this study, we have made an attempt to assess the molecular mechanisms by which miR-32 suppresses the expression of SRCIN1, thereby leading to promotion of proliferation and epithelial-mesenchymal transition of human liver cancer cells. Human liver cancer cell line HepG2 was transfected with miR-32 mimics and its control. The HepG2 cells were assessed for miR-32 expression. The transfected cells were then studied for SRCIN1 expression by luciferase assay, effect of transfection on cell proliferation, and epithelial-mesenchymal transition. SRCIN1 expression was downregulated in the human liver cancer cell line HepG2. Overexpression of SRCIN I inhibited the proliferation of human liver HepG2 cancer cells and blocked epithelial-mesenchymal transition. It was observed that SRCIN1 expression was regulated by miR-32 in human liver cancer cells. Overexpression of miR-32 promoted cell proliferation and epithelial-mesenchymal transition of human liver cancer HepG2 cells. Our data demonstrated that SRCIN1 functions as a tumor suppressor in human liver cancers. Additionally, SRCIN1 functions to inhibit the proliferation and epithelial-mesenchymal transition of human liver cancer HepG2 cells. miRNA-32 was a direct target of SRCIN1. Overexpression of miR-32 promoted cell proliferation and epithelial-mesenchymal transition of human liver cancer HepG2 cells.
机译:MicroRNA通过结合靶MRNA的3'-UTR来调节基因表达的重要作用。在本研究中,我们试图评估miR-32抑制srcin1表达的分子机制,从而导致促进人肝癌细胞的增殖和上皮间过渡转变。用miR-32模拟物转染人肝癌细胞系Hepg2及其对照。评估HepG2细胞的miR-32表达。然后通过荧光素酶测定法研究转染的细胞进行Srcin1表达,转染对细胞增殖的影响,以及上皮 - 间充质转变。 SRCIN1表达在人肝癌细胞系HepG2中下调。 Srcin的过度表达I抑制人肝HepG2癌细胞的增殖并阻断上皮间充质转变。观察到SRCIN1表达受人肝癌细胞中的miR-32调节。 miR-32的过度表达促进了人肝癌Hepg2细胞的细胞增殖和上皮 - 间充质转换。我们的数据表明,SRCIN1作为人肝癌中的肿瘤抑制剂。另外,Srcin1的作用是抑制人肝癌HepG2细胞的增殖和上皮间过渡。 miRNA-32是srcin1的直接靶标。 miR-32的过度表达促进了人肝癌Hepg2细胞的细胞增殖和上皮 - 间充质转换。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号